NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/13/2024
Back to search
Official data from USPTO
NANOTEARS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
61
Latest update
05/13/2024
Trademark type
Word
Nice classes
5
Filing date
08/02/2010
Registration date
06/10/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/13/2024
Last transaction
05/13/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/02/2010
First use in commerce
11/16/2013
Drawing code
4
Owner type
03
Owner location
Aquebogue, NY
Examiner
HERRERA-MARCUS, ROSELLE
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Altaire Pharmaceuticals, Inc.
Representatives
Michael S. Sawaya
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of eye diseases and conditionsan ophthalmic solution formulation and topical preparation that contains colloidal lipids (nanolipids)emulsifiersmultiple aqueous tearlike ingredientscombined with a unique gelling agentwhich when the solution is instilled into the eye increases the viscosity of the solution so that the gelling agent forms a clear gel in the eye for the treatment of ocular disorders as recommended or prescribed by ophthalmologistseye surgeonsoptometrists and can act as drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; an ophthalmic solution that contains a unique gelling agent applicable to the delivery of active ingredients into the eye to lubricate the eye and provide dry eye reliefredness reliefallergy reliefis applicable to the delivery into the eye of anti-infectivesantibioticscombination anti-fungalsanti-virus and anti-inflammatory agents
Publications
History of USPTO decisions and trademark events.
61 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/13/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/13/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/13/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
01/26/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/10/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/21/2019
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/21/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/21/2019
ES8R
TEAS SECTION 8 RECEIVED
06/11/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/09/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/08/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/07/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/22/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/21/2014
GNRT
NON-FINAL ACTION E-MAILED
04/21/2014
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/21/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/28/2014
IUAF
USE AMENDMENT FILED
02/19/2014
EISU
TEAS STATEMENT OF USE RECEIVED
02/19/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/17/2013
EX5G
SOU EXTENSION 5 GRANTED
09/16/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/13/2013
EXT5
SOU EXTENSION 5 FILED
08/22/2013
EEXT
SOU TEAS EXTENSION RECEIVED
08/22/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/26/2013
EX4G
SOU EXTENSION 4 GRANTED
02/25/2013
EXT4
SOU EXTENSION 4 FILED
02/22/2013
EEXT
SOU TEAS EXTENSION RECEIVED
02/22/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/29/2012
EX3G
SOU EXTENSION 3 GRANTED
08/28/2012
EXT3
SOU EXTENSION 3 FILED
08/22/2012
EEXT
SOU TEAS EXTENSION RECEIVED
08/22/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/21/2012
EX2G
SOU EXTENSION 2 GRANTED
03/20/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/20/2012
EXT2
SOU EXTENSION 2 FILED
02/27/2012
EEXT
SOU TEAS EXTENSION RECEIVED
02/27/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/02/2011
EX1G
SOU EXTENSION 1 GRANTED
08/31/2011
EXT1
SOU EXTENSION 1 FILED
08/31/2011
EEXT
SOU TEAS EXTENSION RECEIVED
08/31/2011
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/22/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/25/2011
PUBO
PUBLISHED FOR OPPOSITION
01/25/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/22/2010
ALIE
ASSIGNED TO LIE
12/22/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/30/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/29/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/29/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/13/2010
GNRT
NON-FINAL ACTION E-MAILED
11/13/2010
CNRT
NON-FINAL ACTION WRITTEN
11/13/2010
DOCK
ASSIGNED TO EXAMINER
11/13/2010
MPMK
NOTICE OF PSEUDO MARK MAILED
08/07/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2010
Continuous trademark protection
Get notified about every new filing that threatens NANOTEARS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.